Abstract:
A series of novel benzimidazole and benzothiazole derivatives were designed and synthesized as inhibitors of SIRT1-SIRT3. The target compounds were synthesized from potassium
O-ethyldithiocarbonate through a three-step route. The structures of the obtained compounds were elucidated by
1H NMR and HR-MS. Of all compounds, six showed potent SIRT2-inhibitory activities with IC
50 values ranging from 2.8 to 21.2 μmol·L
-1. Among them, compound
10c displayed the most potent SIRT2-inhibitory activities (IC
50 = 2.8 μmol·L
-1), with more than 35-fold selectivity over SIRT1 and SIRT3 (IC
50>100 μmol·L
-1).